Home » Health » AstraZeneca, Oxford Covid-19 Vaccine Up to 90% Effective in Late-Stage Trials - The Wall Street Journal

By Belel Koje Monday, November 23, 2020 Health

AstraZeneca, Oxford Covid-19 Vaccine Up to 90% Effective in Late-Stage Trials - The Wall Street Journal

Bagikan Berita Ini

0 Response to "AstraZeneca, Oxford Covid-19 Vaccine Up to 90% Effective in Late-Stage Trials - The Wall Street Journal"

Post a Comment

Subscribe to: Post Comments (Atom)